Lack of antimicrobial resistance in Yersinia pestis isolates from 17 countries in the Americas, Africa, and Asia

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 555-558

  Urich, Sandra K ^a   Chalcraft, Linda ^a   Schriefer, Martin E ^a   Yockey, Brook M ^a   Petersen, Jeannine M ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; STREPTOMYCIN; TETRACYCLINE;

AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; BACTERIUM ISOLATE; MULTIDRUG RESISTANCE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; WESTERN HEMISPHERE; YERSINIA PESTIS;

AFRICA; AMERICAS; ANIMALS; ANTI-BACTERIAL AGENTS; ASIA; DRUG RESISTANCE, BACTERIAL; HUMANS; MADAGASCAR; MICROBIAL SENSITIVITY TESTS; PHYLOGEOGRAPHY; PLAGUE; PLASMIDS; PUBLIC HEALTH; SIPHONAPTERA; YERSINIA PESTIS;

EID: 84455170018     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05043-11     Document Type: Article

References (23)

1. Call DR, et al. 2010. blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob. Agents Chemother. 54:590-596.
2. Clinical and Laboratory Standards Institute. 2010. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria: approved guideline, 2nd ed. CLSI document M45-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 8th ed. CLSI document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Dennis DT, Hughes JM. 1997. Multidrug resistance in plague. N. Engl. J. Med. 337:702-704. (Pubitemid 27375480)
5. Dennis DT, Staples EJ. 2009. Plague, p. 597-611. In A. S. Evans and P. S. Brachman (ed.), Bacterial infections of man: epidemiology and control. Plenum Medical Book Co., New York, NY.
6. Eisen RJ, Eisen L, Gage KL. 2009. Studies of vector competency and efficiency of North American fleas for Yersinia pestis: state of the field and future research needs. J. Med. Entomol. 46:737-744.
7. Erickson DL, Anderson NE, Cromar LM, Jolley A. 2009. Bacterial communities associated with flea vectors of plague. J. Med. Entomol. 46: 1532-1536.
8. Eskey CR, Prince FM, Fuller FB. 1951. Double infection of the rat fleas X. cheopis and N. fasciatus with Pasteurella and Salmonella. Public Health Rep. 66:1318-1326.
9. Fricke WF, et al. 2009. Comparative genomics of the IncA/C multidrug resistance plasmid family. J. Bacteriol. 191:4750-4757.
10. Galimand M, et al. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:677-681.
11. Galimand M, Carniel E, Courvalin P. 2006. Resistance of Yersinia pestis to antimicrobial agents. Antimicrob. Agents Chemother. 50:3233-3236. (Pubitemid 44527492)
12. Guiyoule A, et al. 2001. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg. Infect. Dis. 7:43-48. (Pubitemid 32173332)
13. Hinnebusch BJ. 2005. The evolution of flea-borne transmission in Yersinia pestis. Curr. Issues Mol. Biol. 7:197-212. (Pubitemid 41051686)
14. Hinnebusch BJ, Rosso M, Schwan T, Carniel E. 2002. High-frequency conjugated transfer of antibiotic resistance genes to Yersinia pestis in the flea midgut. Mol. Microbiol. 2:349-354. (Pubitemid 35340948)
15. Inglesby T, et al. 2000. Plague as a biological weapon: medical and public health management. JAMA 283:2281-2290. (Pubitemid 30246781)
16. Jones RT, Knight R, Martin AP. 2010. Bacterial communities of disease vectors sampled across time, space, and species. ISME J. 4:223-231.
17. Jones RT, McCormick KF, Martin AP. 2008. Bacterial communities of Bartonella-positive fleas: diversity and community assembly patterns. Appl. Environ. Microbiol. 74:1667-1670. (Pubitemid 351359066)
18. Layton RC, et al. 2011. Levofloxacin cures experimental pneumonic plague in African green monkeys. PLoS Negl. Trop. Dis. 5:e959.
19. Peterson JW, et al. 2010. Protection afforded by fluoroquinolones in animal models of respiratory infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis. Open Microbiol. J. 4:34-46.
20. Stenseth N, et al. 2008. Plague: past, present, and future. PLoS 5:9 -13.
21. Steward J, et al. 2004. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int. J. Antimicrob. Agents 24:609-612. (Pubitemid 39536118)
22. Talbot EA, Gagnon ER, Greenblatt J. 2006. Common ground for the control of multidrug-resistant Salmonella in ground beef. Clin. Infect. Dis. 42:1455-1462.
23. Welch T, et al. 2007. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS One 2:e309.